Phenoxymethylpenicillin (Penicillin V)

DRUG NAME: Phenoxymethylpenicillin (Penicillin V)

1. RF secondary prophylaxis (oral alternative) — when benzathine penicillin IM is unavailable (chronic supply shortage in India)
2. GAS pharyngitis treatment — narrower spectrum than amoxicillin (an antimicrobial stewardship advantage)
3. Dental infections — still used by some dentists in India
4. Post-splenectomy prophylaxis — long-term antibiotic prophylaxis against encapsulated organisms

---

Therapeutic Class: Antibiotic

---

Subclass: Natural Penicillin — Acid-Stable, Oral (Beta-Lactam — Penicillinase-Susceptible)

• Benzylpenicillin (Penicillin G) — natural penicillin but acid-labile (parenteral only)
• Aminopenicillins (amoxicillin, ampicillin) — broader gram-negative spectrum
• Penicillinase-resistant penicillins (cloxacillin) — anti-staphylococcal

---

Speciality:

• Primary Speciality: Infectious Disease
• Also used in: Cardiology, Paediatrics, Haematology

---

Schedule (India):

---

Route(s):

• Oral (tablets — swallowed whole with water; oral suspension/dry syrup — measured with graduated dosing cup/syringe)

---

Biosimilar Status:

---

Formulations Available in India:

---

PHARMACOKINETICS

---

• For acute infections (GAS pharyngitis): QID (every 6 hours) dosing is traditionally recommended to maintain fT>MIC above the threshold for the required proportion of each dosing interval. However, some evidence supports BD or TDS dosing for GAS pharyngitis specifically, because GAS has an extremely low MIC for penicillin (~0.01 mcg/mL) — even with the short half-life and BD dosing, fT>MIC may exceed 50% for this highly susceptible organism. Indian and WHO guidelines for GAS pharyngitis now accept BD dosing (see Indications section).
• For RF prophylaxis: BD dosing (250 mg BD) is the established regimen. The extremely low MIC of GAS means that even the trough levels between BD doses likely exceed the MIC for most of the dosing interval.

---

---

---

ADULT INDICATIONS + DOSING — FOR CLINICIAN USE ONLY

---

1. Empty-stomach dosing is recommended for optimal absorption — take 1 hour before meals or 2 hours after meals. Food reduces absorption by 30–50%. For RF prophylaxis (where consistent drug exposure is critical), empty-stomach compliance should be specifically emphasised.
2. Dosing frequency varies by indication:
3. • Treatment of acute infections (pharyngitis, dental infections): QID (every 6 hours) for 10 days — traditional regimen. BD (every 12 hours) dosing is now accepted for GAS pharyngitis by some guidelines (see below).
   • Prophylaxis (RF, post-splenectomy): BD (every 12 hours) — lower doses, long-term.
4. Antimicrobial spectrum is NARROW — this is an advantage for antimicrobial stewardship (less collateral damage to normal flora) but limits the drug’s utility to infections caused by penicillin-susceptible organisms. Do NOT use empirically for infections where broader coverage is needed.
5. Penicillin allergy screening applies to all penicillin formulations — enquire about allergy history before prescribing.

---

Primary Indications (Approved / Standard in India)

---

1. When to prefer this drug over alternatives:
2. • Prefer phenoxymethylpenicillin when antimicrobial stewardship is a priority — it has the narrowest spectrum among oral antibiotics effective against GAS. Using amoxicillin for pharyngitis provides unnecessary gram-negative coverage and contributes marginally more to resistance selection pressure.
   • Prefer when the prescriber specifically wants a penicillinase-susceptible penicillin for GAS (to avoid broadening spectrum unnecessarily).
   • ℹ️ In practice, the choice between phenoxymethylpenicillin and amoxicillin for GAS pharyngitis is often determined by availability and patient preference rather than pharmacological superiority. Both are equally effective when taken for the full 10-day course.
3. When NOT to use:
4. • ⛔ Confirmed penicillin allergy (IgE-mediated) — use azithromycin (500 mg OD × 5 days or 12 mg/kg/day × 5 days for children) or clarithromycin (250 mg BD × 10 days) as alternatives. ⚠️ Macrolide-resistant GAS has been reported in India (~5–15% in some regions) — if macrolide resistance is suspected, use a first-generation cephalosporin (cephalexin 500 mg BD × 10 days — if non-anaphylactic penicillin allergy) or clindamycin (300 mg TDS × 10 days).
   • ⚠️ Do NOT use for viral pharyngitis — the most common cause of sore throat. Antibiotics for viral pharyngitis drive resistance and provide no benefit. Use clinical criteria (Centor/McIsaac score ≥3) or rapid antigen detection test (RADT) for GAS to guide antibiotic prescribing. In Indian practice, RADTs are increasingly available at tertiary centres and urban clinics but remain uncommon at PHC/CHC level.
   • ⚠️ Do NOT use for peritonsillar abscess (quinsy) — requires drainage + parenteral antibiotics (IV crystalline penicillin or amoxicillin-clavulanate + metronidazole). Oral phenoxymethylpenicillin is inadequate for abscess treatment.
   • ⚠️ Do NOT use empirically for pharyngitis with purulent exudate AND failure to respond to initial treatment — consider GAS treatment failure (possible penicillin-tolerant organism, co-pathogen producing beta-lactamase), gonococcal pharyngitis (sexual history), diphtheria (in endemic areas), or infectious mononucleosis.
5. NLEM India status: ℹ️ Phenoxymethylpenicillin is NOT specifically listed in NLEM India 2022 as a separate antibiotic. Amoxicillin (oral) and benzylpenicillin (injection) ARE listed. However, phenoxymethylpenicillin is referenced in several Indian guidelines for GAS pharyngitis treatment.
6. Typical time to expected clinical response:
7. • Symptom improvement (reduced sore throat, defervescence): 24–48 hours after starting treatment.
   • If no improvement by 48 hours: reassess diagnosis. Consider: viral pharyngitis (most common), peritonsillar abscess, mononucleosis (if ampicillin/amoxicillin-related rash present — note: this would not apply to phenoxymethylpenicillin), non-GAS bacterial pharyngitis, or non-compliance.
   • ℹ️ Bacteriological eradication of GAS occurs over the full 10-day course — clinical improvement precedes bacteriological cure. Do NOT stop early because of symptom resolution.
8. Criteria for treatment failure and switching:
9. • Clinical failure: Persistent or worsening symptoms after 48–72 hours of appropriate therapy with good compliance.
   • Bacteriological failure: Positive throat culture for GAS after completing a full 10-day course (relevant for RF prevention programmes where post-treatment cultures are done).
   • Recurrent GAS pharyngitis (multiple episodes): Consider: (a) re-infection from close contacts (treat household contacts if cultured positive); (b) GAS carrier state (asymptomatic carriage that coincides with viral pharyngitis — does not usually require treatment); © co-pathogen producing beta-lactamase that inactivates penicillin in the pharynx — consider amoxicillin-clavulanate or clindamycin for recurrent episodes.
   • Switch options for recurrence: Amoxicillin-clavulanate (875/125 mg BD × 10 days), clindamycin (300 mg TDS × 10 days), or a single dose of benzathine penicillin IM (to guarantee treatment completion).
10. Mandatory baseline investigations:
11. • Not mandatory for empirical treatment based on clinical criteria (Centor/McIsaac score ≥3).
    • RECOMMENDED where available: Throat swab culture (gold standard for GAS diagnosis — 24–48 hour turnaround). Rapid Antigen Detection Test (RADT) for GAS — point-of-care, result in 5–10 minutes, high specificity (~95%) but moderate sensitivity (~70–90%). If RADT is negative in a clinically suspicious case, send throat culture.
    • RECOMMENDED: ASO titre is NOT useful acutely (rises 1–5 weeks after infection) — relevant only for retrospective RF diagnosis.
12. Specialist initiation:Not required. GAS pharyngitis treatment is appropriate at PHC/CHC level and in primary care. Any registered medical practitioner can prescribe.
13. Indian guideline source: IAP Guidelines on Acute Pharyngitis and RF Prevention (2017) — recommends phenoxymethylpenicillin or amoxicillin as first-line for GAS pharyngitis; API Textbook of Medicine (current edition) — chapter on Upper Respiratory Tract Infections and Rheumatic Fever; ICMR Guidelines on RF/RHD Prevention.
14. Key disease-specific safety warning: ⚠️ Completing the full 10-day course is the most critical message for RF prevention. In Indian practice, premature discontinuation of antibiotics for pharyngitis is extremely common (patients stop once symptoms improve at day 3–5). Incomplete treatment does NOT reliably eradicate GAS from the pharynx and does NOT prevent RF. Counsel emphatically at the time of prescribing: ”You must take this medicine for the full 10 days, even if you feel completely well.“
15. Common dose adjustment scenarios:
16. • Renal impairment: No adjustment needed at standard treatment doses (10-day course) in mild-moderate CKD. In severe CKD (eGFR <15): reduce to 250 mg BD and monitor.
    • Hepatic impairment: No adjustment needed.
    • Elderly: No adjustment beyond renal function considerations.
    • Pregnancy: Safe — standard dosing. See PREGNANCY section.

---

• Benzathine penicillin is unavailable (chronic supply shortage in India — a recurrent national problem since ~2016)
• The patient absolutely refuses IM injections (needle phobia, severe injection site reactions, personal preference)
• IM injection is contraindicated (very rare — e.g., severe coagulopathy, therapeutic anticoagulation with high INR where deep IM injection risks haematoma)

1. When to prefer over alternatives: ⚠️ Oral penicillin V is NEVER the preferred option for RF prophylaxis. It is the designated fallback when benzathine penicillin IM is unavailable or genuinely impossible. If benzathine penicillin becomes available, switch BACK to IM prophylaxis immediately.
2. When NOT to use:
3. • ⛔ Penicillin allergy — use oral erythromycin (250 mg BD) or azithromycin (250 mg OD — less well-established for RF prophylaxis but used at some Indian centres during supply shortages).
   • ⚠️ If the patient is unable or unwilling to take medication twice daily EVERY day for years — oral prophylaxis will be ineffective. Explore alternatives: resolve injection refusal through counselling, pain management strategies (EMLA cream, lidocaine diluent), or consider erythromycin if penicillin-allergic.
   • ⚠️ Do NOT prescribe oral prophylaxis and assume compliance — active follow-up is essential (see Monitoring section).
4. NLEM India status: Phenoxymethylpenicillin is not specifically listed in NLEM 2022. However, it is the standard oral RF prophylaxis agent referenced in ICMR, API Textbook, and IAP guidelines.
5. Time to response: Not applicable — this is prophylaxis, not treatment. Effectiveness is measured by prevention of RF recurrence over years.
6. Treatment failure criteria: Any recurrent RF episode (confirmed by Jones Criteria) while on oral prophylaxis constitutes prophylaxis failure. Action: (a) assess adherence — most ”failures“ are adherence failures; (b) if adherence is truly good (verified by pill counts, pharmacy records, or directly observed therapy), investigate for GAS resistance to penicillin (extremely rare — never confirmed clinically); © switch to benzathine penicillin IM if it has become available.
7. Mandatory baseline investigations:
8. • MANDATORY: Echocardiography (document baseline valvular status — same as for IM prophylaxis).
   • RECOMMENDED: ASO titre, CRP/ESR (if acute RF episode is being evaluated at the time of starting prophylaxis).
9. Specialist initiation: Initial RF diagnosis and classification should be by a physician or cardiologist. Ongoing oral prophylaxis can be managed at the PHC/CHC level — but ONLY with active adherence monitoring (see below). The decision to use oral instead of IM prophylaxis should be made at the specialist level and documented with the rationale.
10. Indian guideline source: API Textbook of Medicine (current edition) — Chapter on Rheumatic Fever and RHD; ICMR Guidelines on RF/RHD Prevention (2008, updated practice); NVHCP Operational Guidelines; IAP Guidelines on RF/RHD (2008, updated practice).
11. Key disease-specific safety warning: ⚠️ Adherence monitoring is MANDATORY for oral RF prophylaxis. Unlike benzathine penicillin IM (where adherence is verified at each injection visit), oral prophylaxis requires specific strategies to monitor and support adherence:
12. • Monthly clinic visits with tablet counting (ask the patient to bring the remaining tablets)
    • Pharmacy refill tracking (is the patient refilling prescriptions regularly?)
    • Direct questioning about missed doses (non-judgmental approach)
    • Family/caregiver involvement (designate a family member to remind the patient daily)
    • Consider directly observed therapy (DOT) — where the patient takes the morning dose under observation of a family member or community health worker
    • Digital reminders (phone alarms, WhatsApp reminders from the RF clinic)
13. Dose adjustment: No renal or hepatic adjustment needed at prophylactic doses (250 mg BD). If patient has severe renal impairment: maintain 250 mg BD (safe at this dose — wide therapeutic index). No pregnancy dose adjustment — continue prophylaxis through pregnancy.

---

1. When to prefer over alternatives: Prefer for confirmed or highly suspected streptococcal non-purulent skin infection where narrow-spectrum therapy is desired (antimicrobial stewardship). In practice, amoxicillin-clavulanate or cloxacillin are more commonly prescribed in Indian outpatient settings because they cover both streptococci AND staphylococci — a practical advantage when the pathogen is uncertain.
2. When NOT to use:
3. • ⚠️ Purulent cellulitis / abscess — likely staphylococcal → requires anti-staphylococcal coverage (cloxacillin, amoxicillin-clavulanate, or cephalexin).
   • ⚠️ Severe cellulitis / spreading erysipelas with systemic signs (fever, tachycardia, leucocytosis) — requires IV antibiotics (IV crystalline penicillin or IV amoxicillin-clavulanate). Oral phenoxymethylpenicillin is inadequate.
   • ⚠️ Diabetic foot infections — polymicrobial, require broader coverage.
   • ⚠️ Bite wounds (human or animal) — polymicrobial, require amoxicillin-clavulanate.
4. NLEM status: Not specifically listed.
5. Time to response: Reduction in erythema and systemic symptoms within 48–72 hours. Persistent or spreading erythema at 72 hours = treatment failure → step up to parenteral therapy.
6. Treatment failure: Escalate to IV crystalline penicillin (for streptococcal) or IV amoxicillin-clavulanate (if staphylococcal cover needed). Blood cultures if systemic sepsis.
7. Baseline investigations: None mandatory for mild cellulitis. Mark the margin of erythema with a skin marker at baseline — this allows objective assessment of progression or regression at follow-up.
8. Specialist initiation: Not required. Primary care appropriate for mild cases.
9. Indian source: API Textbook of Medicine; standard dermatology/surgery textbooks used in Indian practice.
10. Safety warning: ⚠️ Always mark the margin of erythema (ink pen on skin) at the first visit. If the margin extends beyond the marking at 48 hours despite oral antibiotics, the infection is progressing and requires hospitalisation + IV therapy.
11. Dose adjustment: Standard renal/hepatic adjustments as per general sections.

---

1. When to prefer: When the narrowest-spectrum oral penicillin is specifically desired and the infection is likely purely streptococcal (uncommon in dental infections — most are mixed). Phenoxymethylpenicillin has poor anaerobic coverage — Bacteroides, Fusobacterium, and Prevotella species (common oral anaerobes) may have reduced susceptibility.
2. When NOT to use: Dental abscess requiring drainage (antibiotics alone are inadequate — drainage is the primary treatment). Ludwig’s angina (floor-of-mouth cellulitis — requires IV antibiotics + airway management + surgical drainage). Severe dental infections with facial swelling/trismus — require parenteral therapy.
3. NLEM status: Not listed.
4. Time to response: Symptom improvement within 48 hours. If worsening despite antibiotics, consider: inadequate drainage of abscess, need for anaerobic cover, or escalation to broader therapy.
5. Specialist initiation: Not required. Prescribing by dentists is standard.
6. Indian source: Standard dental practice; Indian Dental Association (IDA) prescribing patterns.
7. Safety warning: ⚠️ Antibiotics do NOT substitute for dental procedures (extraction, root canal, drainage). Always address the source of infection.

---

• Metronidazole is preferred over phenoxymethylpenicillin for ANUG in most current Indian practice — superior anaerobic coverage.
• ⚠️ Oral hygiene measures (debridement, chlorhexidine mouthwash) are essential alongside antibiotic therapy.
• HIV testing should be considered in patients with severe or recurrent ANUG — ANUG can be a marker of immunosuppression.
• Indian source: API Textbook of Medicine; dental surgery textbooks.

---

Secondary Indications — Adults Only (Off-label)

---

• ⚠️ Vaccination is the PRIMARY preventive measure. Antibiotic prophylaxis is SUPPLEMENTARY. All post-splenectomy patients must receive:
• • Pneumococcal vaccine (PCV13 + PPSV23 — sequential dosing as per schedule)
  • Meningococcal vaccine (MenACWY ± MenB where available)
  • H. influenzae type b (Hib) vaccine (if not already vaccinated)
  • Influenza vaccine (annually — to reduce secondary bacterial pneumonia risk)
    These vaccinations should ideally be given ≥2 weeks BEFORE elective splenectomy (better immune response with intact spleen) or ≥2 weeks AFTER emergency splenectomy (once recovered).
• ⚠️ Emerging pneumococcal penicillin resistance: In India, approximately 5–15% of S. pneumoniae isolates show intermediate or full resistance to penicillin (non-meningeal breakpoints). For post-splenectomy prophylaxis, the penicillin dose used (250–500 mg BD) achieves serum levels adequate to kill most intermediate-resistant strains. However, if a post-splenectomy patient develops febrile illness despite penicillin prophylaxis, empirical treatment must cover penicillin-resistant pneumococcus — use IV ceftriaxone (not oral penicillin) pending culture results.
• ⚠️ Amoxicillin as alternative: Some protocols use oral amoxicillin 250–500 mg BD instead of phenoxymethylpenicillin for post-splenectomy prophylaxis — higher bioavailability and simpler dosing (can be taken with food). Equally effective. The choice between penicillin V and amoxicillin for this indication is institution-dependent in India.
• Patient education: All post-splenectomy patients must be counselled to:
• • Seek IMMEDIATE medical attention for any febrile illness (temperature >38°C) — even a seemingly mild fever can be the onset of OPSI
  • Carry an emergency supply of amoxicillin-clavulanate or a fluoroquinolone for immediate self-administration if medical care is not accessible within 2 hours of fever onset (rural/remote areas)
  • Carry a splenectomy alert card/medical ID at all times
  • Avoid tick bites, dog bites, and exposure to malaria-endemic areas without prophylaxis (asplenic patients have more severe malaria — P. falciparum)

---

• ⚠️ Prophylaxis alone is insufficient — address predisposing factors simultaneously. In Indian practice, the most common portal of entry for lower-limb cellulitis is interdigital tinea pedis (athlete’s foot). Treat with topical antifungals (clotrimazole, terbinafine) and educate about foot hygiene.
• ⚠️ Lymphoedema management is critical in India (post-filariasis lymphoedema is common in endemic states — Kerala, Bihar, UP, Odisha). Adenolymphangitis (acute episodes) is common and may be prevented by penicillin prophylaxis.
• Erythromycin 250 mg BD is the alternative for penicillin-allergic patients (based on the same PATCH trial data — erythromycin arm showed similar efficacy).
• ⚠️ After stopping prophylaxis, recurrence rate increases — monitor and resume if recurrences restart.

---

---

---

---

---

PAEDIATRIC DOSING (Specialist Only)

---

• Safety monitoring requirements specific to paediatric use:
• • Penicillin allergy assessment is MANDATORY before every new prescription — ask the parent/caregiver: ”Has your child ever had a reaction to penicillin or any antibiotic? What happened?“
  • ⚠️ In children, the most common reason for a parent to report ”penicillin allergy“ is a viral exanthem that occurred coincidentally during an antibiotic course for pharyngitis — the rash was likely viral, not drug-related. >90% of children labelled ”penicillin-allergic“ are NOT truly allergic when formally tested. However, do NOT dismiss the history without assessment — document it and consider formal testing if the child needs long-term penicillin (RF prophylaxis, sickle cell prophylaxis).
  • Monitor adherence — especially for RF prophylaxis and 10-day pharyngitis courses. Parental counselling about course completion is critical.
  • Monitor for GI side effects (diarrhoea, nausea) — common but usually mild.
• Minimum age:
• • Phenoxymethylpenicillin can be used from 1 month of age (oral suspension). It is rarely used in neonates (<28 days) — benzylpenicillin IV is preferred for neonatal infections. If oral penicillin is needed in a neonate (extremely uncommon), specialist neonatal guidance is required.
  • For sickle cell disease prophylaxis: starts at 2–3 months of age (as soon as SCD is diagnosed, ideally through newborn screening).
• Minimum weight: No strict minimum weight — dosing is weight-based (mg/kg). The oral suspension (125 mg/5 mL) allows accurate dosing for small children.
• Formulation suitability for children:
• • Oral suspension (125 mg/5 mL or 250 mg/5 mL): Suitable for all paediatric ages. Reconstitute with water as per manufacturer instructions. Measure with a graduated oral syringe — NOT a household teaspoon (which delivers inconsistent volumes — 3–7 mL instead of the intended 5 mL). ⚠️ Palatability is a significant concern: Phenoxymethylpenicillin suspension has a markedly bitter taste despite flavouring. This is the single biggest practical barrier to paediatric adherence (especially for the 10-day GAS pharyngitis course). Strategies to improve acceptance: mix the measured dose with a small amount of cold fruit juice (orange, mango) or honey (for children >1 year) immediately before giving; chase with a flavoured drink; use a syringe to administer directly to the back of the cheek (bypasses taste buds on the tongue). ℹ️ Amoxicillin suspensions are significantly more palatable (strawberry/banana flavour, less bitter) — this is one reason amoxicillin has largely replaced phenoxymethylpenicillin for paediatric use in India.
  • Tablets (250 mg, 500 mg): Suitable for children ≥6 years who can swallow tablets whole. Do NOT crush (bitter taste, no stability data for crushed form). If the child cannot swallow tablets, use the oral suspension.
• Palatability concerns: See above — bitter taste is the primary issue. Amoxicillin is better tolerated.
• Age-specific pharmacokinetic differences:
• • Neonates (<28 days): Half-life prolonged (1.5–3 hours) due to immature renal tubular secretion. Phenoxymethylpenicillin is almost never used in neonates — IV benzylpenicillin is standard for neonatal infections.
  • Infants (1–12 months): Half-life approaches adult values (~30–60 minutes) by 3–6 months. Standard weight-based dosing applies.
  • Children (1–12 years): Pharmacokinetics similar to adults on a per-kg basis. Weight-based dosing applies.
  • Adolescents (≥12 years or ≥40 kg): Transition to adult dosing (fixed-dose tablets).

---

Neonatal Dosing (<28 days of life)

---

Primary Indications — Paediatric (Approved / Standard in India)

---

• 12.5 mg/kg/dose BD (max 500 mg per dose), OR
• 6.25–8.3 mg/kg/dose QID (max 250 mg per dose)
• Total daily dose: approximately 25 mg/kg/day (max 1 g/day = adult dose)

1. When to prefer over alternatives:
2. • Phenoxymethylpenicillin is the narrowest-spectrum effective antibiotic for GAS pharyngitis — an antimicrobial stewardship advantage.
   • However, amoxicillin (50 mg/kg/day divided BD, max 1 g/day × 10 days) is more commonly prescribed in Indian paediatric practice because: (a) much better palatability of suspension; (b) higher and more reliable bioavailability (~80–90% vs ~60%); © can be taken with food (no empty-stomach requirement); (d) wider availability in Indian pharmacies.
   • IAP 2017 Guidelines list BOTH phenoxymethylpenicillin and amoxicillin as acceptable first-line options. The choice is often determined by availability, palatability, and parental preference.
   • Single-dose IM benzathine penicillin (600,000 IU for <27 kg; 1.2 MU for ≥27 kg) is an alternative when compliance with a 10-day oral course is uncertain — a common scenario in Indian practice. Guarantees treatment completion in a single visit.
3. When NOT to use:
4. • ⛔ Penicillin allergy — use azithromycin (12 mg/kg/day × 5 days, max 500 mg/day) or clarithromycin (15 mg/kg/day divided BD × 10 days).
   • ⚠️ Do NOT prescribe for viral pharyngitis. In children under 3 years, GAS pharyngitis is uncommon (most pharyngitis in this age group is viral). Consider clinical scoring (modified Centor/McIsaac) and RADT where available.
   • ⚠️ Do NOT use shortened courses (<10 days) — incomplete RF prevention.
5. NLEM status: Phenoxymethylpenicillin is not specifically listed in NLEM 2022. Amoxicillin is listed.
6. Time to response: Symptom improvement within 24–48 hours. If no improvement by 48 hours: reassess (viral pharyngitis? peritonsillar abscess? non-compliance?).
7. Treatment failure: Persistent positive throat culture after completing 10-day course. Options: (a) repeat 10-day course; (b) switch to amoxicillin-clavulanate; © single IM benzathine penicillin (guarantees compliance); (d) clindamycin 20 mg/kg/day divided TDS × 10 days.
8. Baseline investigations: Not mandatory. RADT if available. Throat culture if RADT negative and clinical suspicion remains high.
9. Specialist initiation: Not required. PHC/CHC-level prescribing is appropriate.
10. Indian source: IAP Guidelines on Acute Pharyngitis and RF Prevention (2017); IAP Textbook of Pediatrics (current edition); WHO Rheumatic Fever Prevention Guidelines.
11. Safety warning: ⚠️ Complete the full 10-day course — counsel parents emphatically. In Indian paediatric practice, premature discontinuation is extremely common. Parents stop the antibiotic when the child ”feels better“ at day 3–5. This does NOT eradicate GAS and does NOT prevent RF. Consider using a calendar/sticker chart for children — mark 10 days and ask the child to place a sticker each day they take the medicine.
12. Dose adjustment: No renal or hepatic adjustment needed for a standard 10-day course in children with normal organ function.

---

1. Prefer benzathine penicillin IM — ALWAYS. Oral prophylaxis is the last resort.
2. Adherence monitoring is even MORE critical in children than in adults:
3. • ⚠️ Indian studies show <20% adherence with oral penicillin V prophylaxis in children at 1 year.
   • Assign a responsible adult (parent/grandparent) as the ”medication supervisor.“
   • Use a visible pill reminder system (calendar, pill box, mobile alarm).
   • Monthly clinic visits with tablet counting.
   • School health services can assist with adherence monitoring in some Indian states.
   • If adherence is found to be inadequate at any review, escalate back to benzathine penicillin IM immediately — even if it requires sourcing the drug from another pharmacy or hospital.
4. If the child refuses the bitter suspension: Consider: (a) switching to tablets if the child can swallow them (≥6 years — often better accepted than suspension); (b) mixing suspension with cold mango juice (masks bitterness somewhat); © if all fails, this constitutes ”inability to take oral medication“ and the child MUST receive benzathine penicillin IM — counsel the family about injection pain management strategies.
5. Indian source: IAP Guidelines on RF/RHD; NVHCP; API Textbook of Medicine.

---

1. Specialist initiation: ⚠️ MANDATORY. SCD diagnosis and prophylaxis initiation should be by a paediatric haematologist or paediatrician experienced in SCD management. Ongoing prophylaxis can be continued at the PHC level with haematology oversight.
2. Concurrent vaccination is MANDATORY:
3. • PCV13 (pneumococcal conjugate vaccine): as per national immunisation schedule + catch-up doses if needed
   • PPSV23 (pneumococcal polysaccharide vaccine): at age ≥2 years, at least 8 weeks after last PCV13 dose
   • Hib vaccine — per national schedule
   • Meningococcal vaccine — as per availability and specialist recommendation
   • Annual influenza vaccine — recommended
4. NLEM status: Phenoxymethylpenicillin is not specifically listed for SCD prophylaxis in NLEM 2022. However, it is the standard drug used for this indication per ICMR SCD guidelines.
5. Indian source: IAP Haematology Chapter guidelines; ICMR Guidelines on Sickle Cell Disease; standard haematology practice at centres in India’s SCD belt (Chhattisgarh, Jharkhand, Odisha, Maharashtra, Gujarat, Madhya Pradesh, tribal areas of Andhra Pradesh/Telangana).
6. Key safety warning: ⚠️ If a child on penicillin prophylaxis develops fever (≥38°C): treat as a medical emergency. Fever in an asplenic/hyposplenic child can indicate OPSI — a fulminant sepsis syndrome with 50–70% mortality if untreated within 24–48 hours. Parents must be educated to seek IMMEDIATE medical care. Do NOT wait to see if the fever resolves on its own. Empirical IV ceftriaxone should be administered pending cultures at the nearest healthcare facility.
7. Adherence: Same challenges as RF prophylaxis — daily oral medication for years. Family education and regular clinic follow-up are essential. ASHA workers and community health workers in SCD-endemic tribal areas can support adherence monitoring.

---

Secondary Indications — Paediatric (Off-label)

---

---

---

MISSED DOSE / DELAYED DOSE GUIDANCE

---

---

---

---

---

• No withdrawal syndrome — can be stopped and restarted at any time.
• No rebound phenomenon — stopping prophylaxis simply increases the risk of the condition being prevented (RF recurrence, pneumococcal sepsis in asplenic patients), but there is no pharmacological rebound.
• No re-titration needed — resume at the previous dose after any duration of non-adherence.
• Not a biologic — no immunogenicity concern.

---

RECONSTITUTION / ADMINISTRATION QUICK REFERENCE (For Nurses & Clinical Staff)

---

---

---

---

---

---

---

---

RENAL ADJUSTMENT

---

---

---

---

HEPATIC ADJUSTMENT

---

---

---

CONTRAINDICATIONS

---

---

1. Vague childhood history (”my mother says I had a rash to penicillin“): >90% of such patients are NOT truly allergic. If the indication is critical and long-term (RF prophylaxis, SCD prophylaxis), consider formal penicillin skin testing at a tertiary centre (AIIMS, PGI, CMC Vellore, select allergy clinics). If skin test is negative, penicillin can be safely prescribed.
2. Convincing history (documented anaphylaxis/angioedema/urticaria within 1 hour): ⛔ Avoid ALL penicillins. Use alternatives appropriate to the specific indication (erythromycin for RF prophylaxis; azithromycin for GAS pharyngitis; cephalosporins with caution for infections).
3. If penicillin is ESSENTIAL and no adequate alternative exists (e.g., syphilis in pregnancy — not applicable to phenoxymethylpenicillin’s indications, but relevant for the penicillin class): penicillin desensitisation at a tertiary centre.

---

CAUTIONS

---

---

---

PREGNANCY

---

---

---

---

LACTATION

---

---

---

---

ELDERLY

---

---

---

---

---

---

MAJOR DRUG INTERACTIONS

---

---

---

---

---

MODERATE DRUG INTERACTIONS

---

---

COMMON ADVERSE EFFECTS

---

---

---

---

SERIOUS ADVERSE EFFECTS

---

---

---

---

MONITORING REQUIREMENTS

---

---

---

---

---

• Treatment courses (10 days): Monitoring ends when the course is completed and the patient is clinically well. Post-treatment throat culture is optional (see above).
• Prophylaxis (RF, SCD, post-splenectomy): Monitoring continues for the entire duration of prophylaxis — which may be lifelong. Adherence monitoring and annual echocardiography (for RF) or vaccination review (for SCD/post-splenectomy) should never be discontinued as long as the patient remains on prophylaxis.

---

PATIENT COUNSELLING

---

• For sore throat (pharyngitis): ”This medicine kills the germs in your throat that cause sore throat and fever. Taking the full 10-day course protects your heart from a disease called rheumatic fever.“
• For heart protection (RF prophylaxis): ”This medicine protects your heart from further damage caused by rheumatic fever. You need to take it every day, twice a day, for a long time — possibly many years. It is very important not to stop without your doctor’s advice.“
• For preventing serious infection after spleen removal / for sickle cell disease: ”Because your body’s defence system is weaker against certain germs, this medicine helps prevent dangerous infections. Take it every day without missing.“

---

---

• ”If you remember within 6 hours of the missed dose, take it immediately. Then take the next dose at the regular time.“
• ”If more than 6 hours have passed, skip the missed dose and take the next one at the regular time.“
• ”Never take two doses together to make up for a missed one.“
• ”If you are taking this for a sore throat (10-day course), complete all 10 days even if you feel better. If you missed several doses, tell your doctor.“

---

---

• You develop difficulty breathing, swelling of your face/lips/tongue/throat, or a widespread itchy rash (hives) after taking the medicine — this could be a serious allergic reaction
• You develop severe watery diarrhoea (more than 5 times a day) or bloody diarrhoea
• You notice yellowing of your eyes or skin (very rare)
• You develop a skin rash with blisters or mouth sores (very rare)"

---

---

• ”Store tablets in the original pack in a cool, dry place below 30°C. Keep away from moisture.“
• ”If using the liquid medicine (syrup): keep it in the fridge after mixing. If no fridge is available, keep it in the coolest part of the house and use it within 5 days. If kept in the fridge, use within 2 weeks.Throw away any leftover liquid after this time.“
• ”Keep all medicines away from children.“

---

• For sore throat: ”Take for exactly 10 days — do NOT stop earlier even if you feel well. Stopping early can leave germs in your throat that may later harm your heart.“
• For heart protection (RF): ”This medicine is needed for many years — possibly your whole life. Do NOT stop without your doctor’s permission.“
• For preventing infections (SCD / after spleen removal): ”This medicine is needed long-term — possibly lifelong. Do NOT stop without discussing with your doctor.“

---

• ”For sore throat: No follow-up blood test is usually needed. Come back if your symptoms do not improve in 2–3 days or if they get worse.“
• ”For heart protection (RF): Come for a check-up every 3 months. Get a heart scan (echo) once a year.“
• ”For SCD / after spleen removal: Come for regular check-ups as advised by your doctor. Make sure your vaccinations are up to date.“

---

---

• Shake the bottle well before every dose — the medicine settles at the bottom.
• Measure carefully with the syringe or cup — NOT a kitchen spoon.
• The medicine tastes bitter — mixing the dose with a small amount of cold mango juice or orange juice may help. Give the dose quickly and follow with a flavoured drink.
• Complete all 10 days even if the child feels better — stopping early puts the child’s heart at risk.
• If the child vomits within 30 minutes of taking the dose, give the dose again. If vomiting occurs after 30 minutes, do not repeat.
• Watch for skin rash, difficulty breathing, or swelling of the face/lips — if these occur, go to the hospital immediately.
• ⚠️ If the child is on long-term medicine (for heart protection or sickle cell disease): never miss doses. Set a phone alarm. Use a calendar to track doses."

---

---

BRANDS AVAILABLE IN INDIA

---

---

---

• For GAS pharyngitis: switch to amoxicillin (equally effective, widely available).
• For RF prophylaxis: benzathine penicillin IM is the preferred option (if available); if not, amoxicillin has been used off-label at some Indian centres though this is NOT standard guideline-recommended practice.
• For post-splenectomy/SCD prophylaxis: amoxicillin 250 mg BD is an acceptable alternative (used in several international and Indian protocols).

---

---

PRICE RANGE (INR)

---

---

---

---

CLINICAL PEARLS

---

---

VERSION

---

REFERENCES

---

1. CDSCO Product Insert — Phenoxymethylpenicillin Potassium Tablets IP / Dry Syrup, various Indian manufacturers. Approved indications, dosing, contraindications, and adverse effects for the Indian market.
2. Indian Pharmacopoeia 2022 (IP 2022), Indian Pharmacopoeia Commission, Ghaziabad. 8th Edition. Monograph on Phenoxymethylpenicillin Potassium — specifications and official standards.
3. National List of Essential Medicines (NLEM) India 2022, Ministry of Health & Family Welfare, Government of India. Phenoxymethylpenicillin is NOT separately listed. Amoxicillin (oral) and benzylpenicillin (injection) ARE listed.
4. Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition (2023). Chapter 58: Penicillins, Cephalosporins, and Other Beta-Lactam Antibiotics. Pharmacology of phenoxymethylpenicillin — acid stability, pharmacokinetics (oral bioavailability, food effect, renal excretion via OAT transporters), spectrum, clinical uses.
5. Harrison’s Principles of Internal Medicine, 21st Edition (2022). Chapters on: Pharyngitis and Sinusitis; Rheumatic Fever; Sickle Cell Disease; Post-Splenectomy Infections; Cellulitis and Skin Infections. Treatment references for phenoxymethylpenicillin.
6. API Textbook of Medicine, 11th Edition (2019), Association of Physicians of India. Chapters on: Rheumatic Fever and RHD; Upper Respiratory Tract Infections; Streptococcal Infections; Sickle Cell Disease. References phenoxymethylpenicillin for GAS pharyngitis treatment and RF secondary prophylaxis (oral alternative).
7. IAP Guidelines on Acute Pharyngitis and RF Prevention (2017). Recommends phenoxymethylpenicillin (or amoxicillin) as first-line for GAS pharyngitis treatment. Endorses BD dosing for pharyngitis. Recommends benzathine penicillin IM as first-choice for RF secondary prophylaxis with oral penicillin V as alternative.
8. IAP Textbook of Pediatrics, 6th Edition (2021), Indian Academy of Pediatrics. Sections on: GAS pharyngitis, RF/RHD, sickle cell disease, post-splenectomy prophylaxis.
9. ICMR Guidelines on RF/RHD Prevention (2008). Recommends benzathine penicillin IM for secondary prophylaxis; oral penicillin V 250 mg BD as oral alternative. Duration guidelines.
10. NVHCP (National Programme for Prevention and Control of RHD) — Operational Guidelines, Ministry of Health & Family Welfare, Government of India. RF/RHD prophylaxis delivery protocols.
11. ICMR Guidelines on Sickle Cell Disease. References penicillin prophylaxis for SCD patients.
12. WHO Guidelines for Rheumatic Fever and Rheumatic Heart Disease Prevention — Endorses phenoxymethylpenicillin for GAS pharyngitis treatment and as oral alternative for RF secondary prophylaxis.
13. Thomas KS, Crook AM, Nunn AJ, et al. Penicillin to prevent recurrent leg cellulitis (PATCH Trial). N Engl J Med. 2013;368(18):1695–1703. Landmark RCT demonstrating efficacy of penicillin V 250 mg BD for prevention of recurrent cellulitis. Referenced for Secondary Indication 2.
14. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia (PROPS Trial). N Engl J Med. 1986;314(25):1593–1599. Landmark trial demonstrating 84% reduction in pneumococcal sepsis with penicillin prophylaxis in children with SCD. Referenced for SCD prophylaxis dosing.
15. FSRH (Faculty of Sexual and Reproductive Healthcare) UK Clinical Guideline — Drug Interactions with Hormonal Contraception (2019). Confirms no interaction between penicillins and combined oral contraceptives. Referenced for OCP myth debunking.
16. NPPA (National Pharmaceutical Pricing Authority) — Drug Prices Control Order (DPCO) schedule. Phenoxymethylpenicillin is NOT currently price-controlled.
17. PMBJP (Pradhan Mantri Bhartiya Janaushadhi Pariyojana) — Product catalogue reviewed. Phenoxymethylpenicillin availability uncertain.
18. CDSCO website (https://cdsco.gov.in) — Reviewed for banned FDC notifications and NSQ alerts.
19. PvPI (Pharmacovigilance Programme of India) — ADR reporting methodology referenced.
20. Indian Heart Journal — Position statements on RF prophylaxis adherence and oral vs injectable prophylaxis comparison in Indian populations.
21. Multiple Indian adherence studies — From AIIMS, PGIMER Chandigarh, CMC Vellore — documenting <30% adherence with oral penicillin V for RF prophylaxis. Referenced for Clinical Pearl 4 and RF prophylaxis counselling.

---